RMIT signs $2 million health research contract with Chinese institutions
RMIT University has signed a $2 million international research deal that will see collaborative research into Chronic Obstructive Pulmonary Disease (COPD) conducted with Chinese partners.
The deal was signed between Guangdong Provincial Hospital of Chinese Medicine and Guangdong Provincial Academy of Chinese Medical Sciences Research and RMIT's School of Health Sciences.
"The principal aims of our research collaboration are to develop the evidence base in order to inform clinical practice and provide better health outcomes for people throughout the world," Professor Yu Bo Lu, President of the Guangdong Provincial Hospital of Chinese Medicinesaid.
RMIT Deputy Vice-Chancellor Research and Innovation and Vice-President, Professor Daine Alcorn, said current collaborations had led to multi-centre clinical trials of herbal medicines for COPD and acupuncture for allergic rhinitis.
"More clinical studies are expected and research exchanges under this agreement will provide a major contribution to the Traditional and Complementary Medicine Research Program within RMIT's School of Health Sciences, and the Health Innovations Research Institute," Professor Alcorn said.